US Stock MarketDetailed Quotes

VOR Vor Biopharma

Watchlist
  • 0.869
  • +0.037+4.43%
Close Dec 2 16:00 ET
  • 0.853
  • -0.016-1.84%
Post 16:18 ET
59.68MMarket Cap-529P/E (TTM)

About Vor Biopharma Company

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.

Company Profile

SymbolVOR
Company NameVor Biopharma
Listing DateFeb 5, 2021
Issue Price18.00
Founded2015
CEOMr. Robert Ang, M.B.A.,M.B.B.S.
MarketNASDAQ
Employees168
Fiscal Year Ends12-31
Address100 Cambridgepark Drive,Suite 101
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02140
Phone1-617-655-6580
Websitehttp://www.vorbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Robert Ang, M.B.A.,M.B.B.S.
  • Director, President, Interim Principal Financial Officer and Chief Executive Officer
  • 2.69M
  • Dr. Tirtha Chakraborty, PhD
  • Chief Scientific Officer
  • 1.31M
  • Dr. Eyal C. Attar, M.D.
  • Chief Medical Officer
  • --
  • Amy Quinlan
  • Vice President, Finance and Interim Principal Accounting Officer
  • --
  • Matthew R. Patterson
  • Chairman of the Board
  • 185.60K
  • Dr. Joshua Resnick, M.B.A.,M.D.
  • Independent Director
  • 157.50K
  • David Charles Lubner, C.P.A.,M.S.
  • Independent Director
  • 151.60K
  • Dr. Fouad Namouni, M.D.
  • Independent Director
  • --
  • Daniella Beckman
  • Independent Director
  • 164.10K
  • Dr. Sven Ante Lundberg, M.D.
  • Independent Director
  • 152.10K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data